[Plasmacytoid dendritic cell tumor]

Actas Dermosifiliogr. 2011 Apr;102(3):229-31. doi: 10.1016/j.ad.2010.10.004. Epub 2011 Jan 12.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Aged
  • Antigens, CD / analysis
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Asparaginase / administration & dosage
  • Bone Marrow / pathology
  • Bone Marrow Transplantation
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Dendritic Cells / chemistry
  • Dendritic Cells / pathology*
  • Disease Progression
  • Doxorubicin / administration & dosage
  • Humans
  • Immunophenotyping
  • Leukemia, Myelomonocytic, Acute / pathology
  • Lymph Nodes / pathology
  • Lymphoma, Non-Hodgkin / diagnosis
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / pathology*
  • Lymphoma, Non-Hodgkin / surgery
  • Male
  • Mercaptopurine / administration & dosage
  • Methotrexate / administration & dosage
  • Middle Aged
  • Prednisone / administration & dosage
  • Prognosis
  • Remission Induction
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / surgery
  • Transplantation, Homologous
  • Vincristine / administration & dosage

Substances

  • Antigens, CD
  • Cytarabine
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Mercaptopurine
  • Asparaginase
  • Prednisone
  • Methotrexate
  • Daunorubicin

Supplementary concepts

  • CCG-141 protocol
  • CHOP protocol